eGFR: Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula MDRD, CKD-EPI or Cockroft-Gault?

Sponsor
Medical University of Warsaw (Other)
Overall Status
Completed
CT.gov ID
NCT02443363
Collaborator
(none)
170
1
5
33.8

Study Details

Study Description

Brief Summary

The study included 300 patients who are post-kidney transplantation (> 3 months and <10 years). An analysis of body composition using bioelectrical impedance, calculated BMI and serum creatinine was determined. Glomerular filtration rate (GFR) was calculated using the formula CKD-EPI, Modification of Diet in Renal Disease (MDRD) and Cockroft-Gault.

Condition or Disease Intervention/Treatment Phase
  • Other: Estimating of formula MDRD, CKD-EPI, Cockroft-Gault,
  • Device: Tanita BC 418- Bioelectrical impedance analysis

Study Design

Study Type:
Observational
Actual Enrollment :
170 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Estimated Glomerular Filtration Rate After Kidney Transplantation - the Formula Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) or Cockroft-Gault?
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Sep 1, 2015
Actual Study Completion Date :
Sep 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Patients After Kidney Transplantation

A total of 300 consecutive patients admitted to routine visit in Transplant Centre with functioning graft longer than 3 months to 10 years

Other: Estimating of formula MDRD, CKD-EPI, Cockroft-Gault,

Device: Tanita BC 418- Bioelectrical impedance analysis
The device measured the size of total body water (TBW), fat mass (FM%), visceral fat%, fat free mass (FFM), and basal metabolic rate (BMR) (kcal).

Outcome Measures

Primary Outcome Measures

  1. Differences in estimating GFR using formula MDRD, CKD-EPI and Cockroft-Gault in short and long-term postoperative period. [1 day]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • give voluntary consent to participate in the study

  • functioning graft longer than 3 months to 10 years

  • no clinical cardiovascular disease during the 6 months preceding entry

  • stable graft function- glomerular filtration rate > 30 ml/min/1.73 m2, creatinine concentration <2.5 mg/dl

Exclusion Criteria:
  • not meet the above criteria

  • episode of illness (for example: infection)

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Warsaw Warsaw Mazovian Poland 02-091

Sponsors and Collaborators

  • Medical University of Warsaw

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Łukasz Czyżewski, Łukasz Czyżewski, Medical University of Warsaw
ClinicalTrials.gov Identifier:
NCT02443363
Other Study ID Numbers:
  • GFR/KTx/2015/04
First Posted:
May 13, 2015
Last Update Posted:
Oct 2, 2015
Last Verified:
Sep 1, 2015

Study Results

No Results Posted as of Oct 2, 2015